UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022717
Receipt number R000026173
Scientific Title Analysis of the Evidence-practice Gap to Facilitate Proper Medical Care for the Elderly: Investigation, using Databases, of Utilization Measures for National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) in the Kyoto University Onsite Center
Date of disclosure of the study information 2016/06/13
Last modified on 2016/12/13 09:50:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of the Evidence-practice Gap to Facilitate Proper Medical Care for the Elderly: Investigation, using Databases, of Utilization Measures for National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) in the Kyoto University Onsite Center

Acronym

Analysis of the evidence-practice gap for the elderly using NDB in Japan

Scientific Title

Analysis of the Evidence-practice Gap to Facilitate Proper Medical Care for the Elderly: Investigation, using Databases, of Utilization Measures for National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) in the Kyoto University Onsite Center

Scientific Title:Acronym

Analysis of the evidence-practice gap for the elderly using NDB in Japan

Region

Japan


Condition

Condition

Medical practice for elderly people (potentially inappropriate medication (PIMs), cancer, chronic kidney disease, end-of-life care)

Classification by specialty

Medicine in general Hematology and clinical oncology Nephrology
Geriatrics

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify evidence-practice gaps in elderly patients in Japan

Basic objectives2

Others

Basic objectives -Others

To clarify gaps between practice and evidence in PIMs, Cancer, CKD and end-of-life care

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Frequency and newly prescription rate of PIMs and quality and cost of cancer, CKD and end-of-life care

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who have visited hospitals in Japan since April 2009

Key exclusion criteria

Patients with rare disease of which the number is less than 10 in the database

Target sample size

20000000


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takeo Nakayama

Organization

Kyoto University

Division name

Graduate School of Medicine/School of Public Health

Zip code


Address

Yoshida Konoe-cho, Sakyo-ku, Kyoto

TEL

075-753-9477

Email

nakayama.takeo.4a@kyoto-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name In charge of Conflict of Interest

Organization

Kyoto University

Division name

Department of General Affairs and Human Resources, Graduate School of Medicine

Zip code


Address

Yoshida Konoe-cho, Sakyo-ku, Kyoto

TEL

075-753-4305

Homepage URL


Email

060rieki-sohan@mail2.adm.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 06 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2016 Year 06 Month 13 Day

Date of IRB


Anticipated trial start date

2016 Year 08 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Design: Cross-sectional
Subjects: Patients who were registered in National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) and satisfied the criteria


Management information

Registered date

2016 Year 06 Month 13 Day

Last modified on

2016 Year 12 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026173


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name